Le Lézard
Classified in: Health
Subjects: CHI, PDT, CFG, MAT, DEI

Federal announcement to restrict marketing and sales of nicotine pouches a needed move to protect youth


OTTAWA, ON, March 21, 2024 /CNW/ - In an important move toward protecting young people from becoming addicted to nicotine, the federal government has announced plans for new measures regarding nicotine pouches, including restricting advertising, flavours and place of sale. Minister of Health Mark Holland made the announcement yesterday, stating that he wants nicotine pouch products to be sold only in pharmacies from behind the counter. At present, in most provinces, nicotine pouches can be sold in any store, including convenience stores and gas stations. The Canadian Cancer Society applauds Minister Holland for this announcement.

In July of last year, a sister company of Imperial Tobacco Canada Ltd. was given approval to sell flavoured nicotine pouches to people of any age under the Natural Health Product Regulations. When these products hit shelves in October it was the first time in over 100 years that a nicotine product from a tobacco company was allowed to be legally sold to minors.

When launching nicotine pouches on the market, Imperial Tobacco aggressively promoted the products in ways that reached young people including through lifestyle advertising, social media and advertisements in convenience stores next to candy and chocolate bars.

"Federal restrictions on the sale and marketing of nicotine pouches will help prevent nicotine addiction among youth and protect them from tobacco industry marketing strategies," says Rob Cunningham, Senior Policy Analyst, Canadian Cancer Society. "We need to ensure the dramatic rise in  youth vaping does not happen all over again."

Yesterday's announcement comes weeks after British Columbia in February restricted the sale of nicotine pouches in the province to behind the counter in pharmacies. Quebec implemented a similar approach, where nicotine pouches are sold only in pharmacies, and the Quebec Order of Pharmacists has recommended sales only be from behind the counter.

In November 2023, the Canadian Cancer Society joined with other health organizations to call on the federal government to take action and immediately close down the loophole that allows nicotine pouches to be sold without adequate restrictions. Later that month, Minister Holland committed to making changes.

The overwhelming majority of people who smoke began as teenagers or pre-teens. While progress has been made to reduce youth smoking in Canada, youth are now turning to other nicotine products in high numbers, including vaping. In the 2021-2022 school year, among high school students in grades 10-12 in Canada, 24% of youth were vaping, compared with 9% seven years earlier. With flavored nicotine pouches hitting the market last year, there's a renewed risk of young people becoming addicted to these new tobacco industry products.

About the Canadian Cancer Society

The Canadian Cancer Society works tirelessly to save and improve lives. We fund the brightest minds in cancer research. We provide a compassionate support system for all those affected by cancer, across Canada and for all types of cancer. As the voice for people who care about cancer, we work with governments to shape a healthier society. No other organization does all that we do to make lives better today and transform the future of cancer forever.

Help us make a difference. Call 1-888-939-3333 or visit cancer.ca today.

SOURCE Canadian Cancer Society (National Office)


These press releases may also interest you

at 03:05
Owkin, the first end-to-end AI-biotech unicorn that provides best-in-class AI-driven precision drug discovery, development and diagnostics, has announced its expansion into the DACH region (Germany, Austria and Switzerland) following partnerships...

at 03:05
We are excited to share our latest development status. We are pleased to announce that the enrollment of patients in the Phase III clinical trial of DFP-14323 in combination with Afatinib (20 mg/day) versus Afatinib (40 mg/day) alone in stage...

at 02:50
Two hospitals in Belgium are successfully live with the public cloud service from international medical imaging IT and cybersecurity company Sectra (STOCKHOLM: SECT-B). As the first to use Sectra One Cloud in the Benelux countries, the two hospitals...

at 02:03
Barrington James, a global leader in Life Science Recruitment, proudly announces the acquisition of S3 Science Recruitment, a firm renowned for its expertise in drug discovery, medical research, and the broader field of life sciences. Terms of the...

at 02:00
July 3, 2024 Amsterdam, the Netherlands ? Royal Philips , a global leader in health technology, today announced the appointment of Ms Ling Liu as the Chief Region Leader of Philips Greater China, effective immediately. Ms Liu is now a member of...

at 01:39
Hansa Biopharma, "Hansa" , will publish its interim report for January-June 2024 on July 18, 2024. Interested parties may join the Company's quarterly conference call on the same date at 14:00 CEST/8:00 AM EST. The event will be hosted by Søren...



News published on and distributed by: